Efficacy-oriented compatibility for component-based Chinese medicine
- PMID: 25864650
- PMCID: PMC4594187
- DOI: 10.1038/aps.2015.8
Efficacy-oriented compatibility for component-based Chinese medicine
Abstract
Single-target drugs have not achieved satisfactory therapeutic effects for complex diseases involving multiple factors. Instead, innovations in recent drug research and development have revealed the emergence of compound drugs, such as cocktail therapies and "polypills", as the frontier in new drug development. A traditional Chinese medicine (TCM) prescription that is usually composed of several medicinal herbs can serve a typical representative of compound medicines. Although the traditional compatibility theory of TCM cannot be well expressed using modern scientific language nowadays, the fundamental purpose of TCM compatibility can be understood as promoting efficacy and reducing toxicity. This paper introduces the theory and methods of efficacy-oriented compatibility for developing component-based Chinese medicines.
Figures
Similar articles
-
Fangjiomics: revealing adaptive omics pharmacological mechanisms of the myriad combination therapies to achieve personalized medicine.Acta Pharmacol Sin. 2015 Jun;36(6):651-3. doi: 10.1038/aps.2015.33. Acta Pharmacol Sin. 2015. PMID: 26036241 Free PMC article. No abstract available.
-
Diverse array-designed modes of combination therapies in Fangjiomics.Acta Pharmacol Sin. 2015 Jun;36(6):680-8. doi: 10.1038/aps.2014.125. Epub 2015 Apr 13. Acta Pharmacol Sin. 2015. PMID: 25864646 Free PMC article. Review.
-
HERB: a high-throughput experiment- and reference-guided database of traditional Chinese medicine.Nucleic Acids Res. 2021 Jan 8;49(D1):D1197-D1206. doi: 10.1093/nar/gkaa1063. Nucleic Acids Res. 2021. PMID: 33264402 Free PMC article.
-
[Development and application of component-based Chinese medicine theory].Zhongguo Zhong Yao Za Zhi. 2017 Nov;42(21):4054-4058. doi: 10.19540/j.cnki.cjcmm.2017.0161. Zhongguo Zhong Yao Za Zhi. 2017. PMID: 29271139 Chinese.
-
Herb pairs containing Angelicae Sinensis Radix (Danggui): A review of bio-active constituents and compatibility effects.J Ethnopharmacol. 2016 Apr 2;181:158-71. doi: 10.1016/j.jep.2016.01.033. Epub 2016 Jan 22. J Ethnopharmacol. 2016. PMID: 26807913 Review.
Cited by
-
Efficacy analysis and research progress of complementary and alternative medicines in the adjuvant treatment of COVID-19.J Biomed Sci. 2023 May 3;30(1):30. doi: 10.1186/s12929-023-00923-5. J Biomed Sci. 2023. PMID: 37138292 Free PMC article. Review.
-
Inhibition Effects of Patchouli Alcohol, Carvacrol, p-Cymene, Eucalyptol and Their Formulations Against Influenza Virus Pneumonia Through TLR4/NF-κB/NLRP3 Signaling Pathway.Chem Biol Drug Des. 2025 Aug;106(2):e70150. doi: 10.1111/cbdd.70150. Chem Biol Drug Des. 2025. PMID: 40757669 Free PMC article.
-
A Novel Method for Evaluating the Cardiotoxicity of Traditional Chinese Medicine Compatibility by Using Support Vector Machine Model Combined with Metabonomics.Evid Based Complement Alternat Med. 2016;2016:6012761. doi: 10.1155/2016/6012761. Epub 2016 Aug 23. Evid Based Complement Alternat Med. 2016. PMID: 27610185 Free PMC article.
-
A critical courier role of volatile oils from Dalbergia odorifera for cardiac protection in vivo by QiShenYiQi.Sci Rep. 2017 Aug 4;7(1):7353. doi: 10.1038/s41598-017-07659-x. Sci Rep. 2017. PMID: 28779167 Free PMC article.
-
Proteomics Study Reveals the Anti-Depressive Mechanisms and the Compatibility Advantage of Chaihu-Shugan-San in a Rat Model of Chronic Unpredictable Mild Stress.Front Pharmacol. 2022 Jan 17;12:791097. doi: 10.3389/fphar.2021.791097. eCollection 2021. Front Pharmacol. 2022. PMID: 35111057 Free PMC article.
References
-
- 2Sams-Dodd F. Target-based drug discovery: is something wrong? Drug Discov Today 2005; 10: 139–47. - PubMed
-
- 3Zhang Bl, Wang Yy. Theories and Methods Used in the Research of Modern Chinese Medicine by Drug Combination Chin J Nat Med 2005; 3: 258–61.
-
- 4Szuromi P, Vinson V, Marshall E. Rethinking drug discovery Science 2004; 303: 1795.
-
- 5Yang Y, Adelstein SJ, Kassis AI. Target discovery from data mining approaches Drug Discov Today 2012; 17: S16–23. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources